Optavia – MedifastCompany overview
-
(Source: Medifast)
AcedIt program
The AcedIt program provides a platform to recognize team members for their exceptional work that supports business goals and reflects the basic cultural values. It encourages gratitude, relationships, and make a supportive workplace community. With a 93% activation rate and 65% active users, the platform exhibits high engagement rate. The platform also teamed up with the LiveWell wellness initiative to focus on the health and well-being of the employees.
-
(Source: Medifast)
Medifast's OPTAVIA ASCEND Strategy
Medifast introduced OPTAVIA ASCEND in January 2025. It's a new line of high-protein, fiber-rich mini meals and daily nutrient packs. The products are part of two science-backed plans designed for people using GLP-1 medications and for those who want to maintain weight loss. These meals help preserve weak muscle, which can be lost quickly during weight loss. Use of GLP-1 medications can also trigger this. The plans include personalized coaching, community support, and a collaboration with LifeMD to provide access to medication. It aims to improve overall health through accurate weight loss and proper results.
-
(Source: Medifast)
OPTAVIA’s lifestyle lessons for better metabolic health
In January 2026, OPTAVIA released the second episode of its docuseries, “Health by Design: Spain”. The episode shows the way communities in Galicia and Madrid support metabolic health through better lifestyles, balanced diets, and strong social connections. It was hosted by Dr. Wayne Andersen and Nicholas Johnson and thousands of coaches from different parts of the world have participated in this. They shared varied ideas about social bonds, routines, and community-oriented living. They believe that these factors can help address America’s metabolic health challenges.
-
(Source: Medifast)
Medifast's metabolic synchronization strategy
In October 2025, Medifast introduced Metabolic Synchronization™, a science-backed approach created for the betterment of metabolic functions and improve overall health. The system targets excess fat, preserves lean muscle, and protects healthy muscle. It will help achieve a 14% reduction in abundant fat and 98% lean mass retention in 16 weeks. The program includes clinical research, coach-guided plans, and new strategies to help individuals maintain results even when facing challenges like GLP-1 plateaus. Backed by over 40 years of clinical data, the program aims to reach a new phase in Medifast’s mission to promote lifelong health. Also, additional products are planned for 2026.
-
(Source: Medifast)
OPTAVIA gets major marketing campaign to raise awareness
The multi-million‑dollar nationwide marketing campaign of Medifast increases awareness of the OPTAVIA brand and attract new customers. The campaign is supported by a $30 million investment and spreads across digital, social, and traditional media. This strategy aims to make the brand more visible through improved engagement. The company believed that this would attract new customers and support further growth of the business. This effort is an important part of Medifast’s broader plan to expand reach and support its coaching network.
-
(Source: Medifast)
New initiatives aim to enhance coach productivity and growth
Medifast plans to improve the OPTAVIA coach network by giving coaches better tools, data, and support systems to help them grow their businesses and attracts more customers. The company has proposed new programs and digital resources that make it easier for coaches to track progress, workflow, and build their leadership skills. These steps aim to increase coach productivity, support customer acquisition, and make it simpler for both new and experienced coaches to succeed in the business.
-
(Source: Medifast)
Continued cost efficiency via “Fuel for the Future”
Medifast continues to push its “Fuel for the Future” cost efficiency program, which has helped reduce expenses in the the business. In 2024, these efforts made up to $21 million in savings, and the company is ready to target another $15 million to $20 million in savings in 2025. The money saved is being used to support priorities like product innovation and other marketing initiatives that can help expand the brand.
Explore More Companies
Revenue $602.5 million
Revenue at Medifast, Inc. fell 43.8% year over year to $602.5 million in 2024.
Active earning coaches 27,100
Active earning OPTAVIA coaches totaled 27,100 at year-end 2024, a 34.1% decline compared to the previous year.
Average revenue per coach $4,391
In the fourth quarter of 2024, average revenue per active earning OPTAVIA coach totaled $4,391, a 5.5% year-over-year decline.
Gross Profit $444.6 Million
In 2024, gross profit came in at $444.6 million, down sharply from $775.9 million in 2023.
Net income $2.1 million
For 2024, net income came in at $2.091 million, versus $99.4 million in 2023.
Stockholders’ equity $210.1 million
At December 31, 2024, stockholders’ equity was $210.1 million, up from $201.5 million the previous year.
Cash & investments $162.3 million
At the end of 2024, cash, cash equivalents, and investment securities totaled $162.3 million, compared with $150.0 million a year earlier.
Lives impacted 3+ million
More than 3 million lives have been impacted by OPTAVIA’s health and wellness programs.
Product sales share 96.8%
In 2024, product sales accounted for roughly 96.8% of total revenue.
Authorized shares 21.5 million
There are 21.5 million authorized shares, with 20.0 million common shares and 1.5 million preferred shares.
Revenue
Total Sales
2024 : $602 million
Top Achievements
- Ranked #19 in 2025 DSN Global 100.
- Named to US News & World Report’s List of Best Companies to Work For within the food and drink industry.
March 2, 2026Medifast schedules release of Q4, full-year earnings
May 1, 2026Medifast details leadership succession plan
November 04, 2025Medifast announced third-quarter 2025 financials
October 27, 2025Medifast shifts strategy to focus on metabolic health
September 15, 2025Research points to metabolic health benefits from Medifast’s 5 & 1 plan
April 04, 2025Medifast shares second-quarter 2025 earnings update
April 28, 2025Medifast released Q1 2025 financial results
July 01, 2025Medifast debuts OPTAVIA ASCEND product line aimed at GLP-1 users
January 08, 2025Medifast introduced high-protein mini meals for GLP-1 users
June 18, 2024US News & World Report recognizes Medifast among best companies to work for
< > -
-
-
-
-
-
—Dan Chard
Chairman & CEO of Medifast
—Dan Chard
Chairman & CEO of Medifast
—Dr. Satya Jonnalagadda
Medifast Vice President of Scientific & Clinical Affairs
—Dr. Satya Jonnalagadda
Medifast Vice President of Scientific & Clinical Affairs
—Dan Chard
Chairman & CEO of Medifast